Nieuw-Zeeland - Engels - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - aripiprazole 15mg;   - tablet - 15 mg - active: aripiprazole 15mg   excipient: hyprolose iron oxide yellow lactose monohydrate magnesium stearate maize starch microcrystalline cellulose - abilify is indicated of the treatment of schizophrenia including maintenance of clinical improvement during continuation therapy.

Nieuw-Zeeland - Engels - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - aripiprazole 30mg;   - tablet - 30 mg - active: aripiprazole 30mg   excipient: hyprolose iron oxide red lactose monohydrate magnesium stearate maize starch microcrystalline cellulose - abilify is indicated of the treatment of schizophrenia including maintenance of clinical improvement during continuation therapy.

Nieuw-Zeeland - Engels - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - aripiprazole 5mg;   - tablet - 5 mg - active: aripiprazole 5mg   excipient: hyprolose indigo carmine lactose monohydrate magnesium stearate maize starch microcrystalline cellulose - abilify is indicated of the treatment of schizophrenia including maintenance of clinical improvement during continuation therapy.

Verenigde Staten - Engels - NLM (National Library of Medicine)

bryant ranch prepack - aripiprazole (unii: 82vfr53i78) (aripiprazole - unii:82vfr53i78) - aripiprazole 5 mg - abilify oral tablets, orally-disintegrating tablets, and oral solution are indicated for the treatment of: - schizophrenia [see clinical studies (14.1)] - acute treatment of manic and mixed episodes associated with bipolar i disorder [see clinical studies (14.2)] - adjunctive treatment of major depressive disorder [see clinical studies (14.3)] - irritability associated with autistic disorder [see clinical studies (14.4)] - treatment of tourette's disorder [see clinical studies (14.5)] abilify injection is indicated for the treatment of: - agitation associated with schizophrenia or bipolar mania [see clinical studies (14.6)] abilify is contraindicated in patients with a history of a hypersensitivity reaction to aripiprazole. reactions have ranged from pruritus/urticaria to anaphylaxis [see adverse reactions (6.2)] . pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to atypical antipsychotics, including abilify, during pregnancy. healthcare pro

Verenigde Staten - Engels - NLM (National Library of Medicine)

otsuka america pharmaceutical, inc. - aripiprazole (unii: 82vfr53i78) (aripiprazole - unii:82vfr53i78) - aripiprazole 2 mg - abilify mycite, a drug-device combination product comprised of aripiprazole tablets embedded with an ingestible event marker (iem) sensor intended to track drug ingestion, is indicated for the: - treatment of adults with schizophrenia. - treatment of bipolar i disorder acute treatment of adults with manic and mixed episodes as monotherapy and as adjunct to lithium or valproate. maintenance treatment of adults as monotherapy and as adjunct to lithium or valproate. - acute treatment of adults with manic and mixed episodes as monotherapy and as adjunct to lithium or valproate. - maintenance treatment of adults as monotherapy and as adjunct to lithium or valproate. - adjunctive treatment of adults with major depressive disorder. limitations of use: - the ability of the abilify mycite to improve patient compliance or modify aripiprazole dosage has not been established [see dosage and administration (2.1)] . - the use of abilify mycite to track drug ingestion in "real-time" or during an emergency is not recommended

Verenigd Koninkrijk - Engels - MHRA (Medicines & Healthcare Products Regulatory Agency)

otsuka pharmaceuticals (u.k. - aripiprazole - tablet - 10mg

Verenigd Koninkrijk - Engels - MHRA (Medicines & Healthcare Products Regulatory Agency)

otsuka pharmaceuticals (u.k. - aripiprazole - tablet - 15mg

Verenigd Koninkrijk - Engels - MHRA (Medicines & Healthcare Products Regulatory Agency)

otsuka pharmaceuticals (u.k. - aripiprazole - tablet - 30mg

Verenigd Koninkrijk - Engels - MHRA (Medicines & Healthcare Products Regulatory Agency)

otsuka pharmaceuticals (u.k. - aripiprazole - tablet - 5mg

Europese Unie - Engels - EMA (European Medicines Agency)

otsuka pharmaceutical netherlands b.v. - aripiprazole - schizophrenia; bipolar disorder - psycholeptics - abilify is indicated for the treatment of schizophrenia in adults and in adolescents aged 15 years and older.abilify is indicated for the treatment of moderate to severe manic episodes in bipolar i disorder and for the prevention of a new manic episode in adults who experienced predominantly manic episodes and whose manic episodes responded to aripiprazole treatment.abilify is indicated for the treatment up to 12 weeks of moderate to severe manic episodes in bipolar i disorder in adolescents aged 13 years and older.